Clinical Trial Update: Impact Of Bacterial Resistance On Healthcare Costs For Hospitalized Patients With Complicated Intra-Abdominal Infections

View source ↗

Summary

The completed study evaluated how bacterial resistance affects healthcare costs for hospitalized patients with complicated intra-abdominal infection, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Complicated Intra-Abdominal Infection | Status: COMPLETED | Results posted: 2012-08-06